Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults.

Horowitz MP, Milanese C, Di Maio R, Hu X, Montero LM, Sanders LH, Tapias V, Sepe S, van Cappellen WA, Burton EA, Greenamyre JT, Mastroberardino PG.

Antioxid Redox Signal. 2011 Aug 15;15(4):855-71. doi: 10.1089/ars.2010.3629. Epub 2011 Jun 6.

2.

Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction.

Di Giovanni G, Pessia M, Di Maio R.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):419-29. Review.

PMID:
22483306
3.

Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease.

Huh SH, Chung YC, Piao Y, Jin MY, Son HJ, Yoon NS, Hong JY, Pak YK, Kim YS, Hong JK, Hwang O, Jin BK.

J Immunol. 2011 Jul 15;187(2):960-9. doi: 10.4049/jimmunol.1100009. Epub 2011 Jun 17.

4.

Dopaminergic neurons.

Chinta SJ, Andersen JK.

Int J Biochem Cell Biol. 2005 May;37(5):942-6. Epub 2004 Dec 2. Review.

PMID:
15743669
5.

PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.

Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, Yanagisawa D, Nishimura K, Taniguchi T, Kiso Y, Yoshimoto K, Agatsuma T, Koide-Yoshida S, Iguchi-Ariga SM, Shimohama S, Ariga H.

Neurobiol Dis. 2006 Oct;24(1):144-58. Epub 2006 Jul 24.

PMID:
16860563
6.

Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture.

O'Malley EK, Sieber BA, Black IB, Dreyfus CF.

Brain Res. 1992 Jun 5;582(1):65-70.

PMID:
1379874
8.

Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.

Liang CL, Wang TT, Luby-Phelps K, German DC.

Exp Neurol. 2007 Feb;203(2):370-80. Epub 2006 Sep 28.

PMID:
17010972
9.

Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.

Perier C, Bender A, García-Arumí E, Melià MJ, Bové J, Laub C, Klopstock T, Elstner M, Mounsey RB, Teismann P, Prolla T, Andreu AL, Vila M.

Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.

10.

Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.

Proença MB, Dombrowski PA, Da Cunha C, Fischer L, Ferraz AC, Lima MM.

Neuropharmacology. 2014 Jan;76 Pt A:118-26. doi: 10.1016/j.neuropharm.2013.08.024. Epub 2013 Sep 4.

PMID:
24012539
11.

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.

Hastings TG.

J Bioenerg Biomembr. 2009 Dec;41(6):469-72. doi: 10.1007/s10863-009-9257-z.

PMID:
19967436
12.
13.

Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.

Norazit A, Meedeniya AC, Nguyen MN, Mackay-Sim A.

Brain Res. 2010 Nov 11;1360:119-29. doi: 10.1016/j.brainres.2010.08.070. Epub 2010 Aug 31.

PMID:
20807515
14.
15.

Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?

Ziv I, Offen D, Barzilai A, Haviv R, Stein R, Zilkha-Falb R, Shirvan A, Melamed E.

J Neural Transm Suppl. 1997;49:195-202. Review.

PMID:
9266428
16.

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC.

Brain. 2009 Jul;132(Pt 7):1795-809. doi: 10.1093/brain/awn323. Epub 2008 Dec 3.

17.

Substantia nigra control of basal ganglia nuclei.

Guatteo E, Cucchiaroni ML, Mercuri NB.

J Neural Transm Suppl. 2009;(73):91-101. Review.

PMID:
20411770
18.

The role of glial cells in Parkinson's disease.

Vila M, Jackson-Lewis V, Guégan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S.

Curr Opin Neurol. 2001 Aug;14(4):483-9. Review.

PMID:
11470965
19.

Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.

Ahmadi FA, Grammatopoulos TN, Poczobutt AM, Jones SM, Snell LD, Das M, Zawada WM.

Neurochem Res. 2008 May;33(5):886-901. Epub 2007 Nov 10.

PMID:
17992568
20.
Items per page

Supplemental Content

Write to the Help Desk